# SIKE1

## Overview
SIKE1 (suppressor of IKBKE 1) is a gene that encodes a regulatory protein involved in modulating immune responses and maintaining cellular homeostasis. The SIKE1 protein functions primarily as a negative regulator of the IKKε and TBK1 kinases, which are pivotal in the activation of the type I interferon response pathway, thereby playing a crucial role in antiviral immunity (Marion2013Mechanism). Structurally, the protein is characterized by a coiled-coil domain that facilitates its interactions with other proteins, such as TBK1, and allows it to form various oligomeric states (Deng2016Suppressor; forbes2010biochemical). Beyond its immune regulatory functions, SIKE1 is also implicated in DNA repair and genomic stability as part of the STRIPAK complex, which is essential for the repair of DNA double-strand breaks (An2022Combinatorial). Clinically, SIKE1 is significant in the context of cardiac health, where its expression levels are linked to conditions such as hypertrophic and dilated cardiomyopathy, suggesting its potential as a therapeutic target for cardiac hypertrophy and heart failure (Deng2016Suppressor).

## Structure
The SIKE1 protein is composed of 207 amino acids and contains a coiled-coil domain, which is crucial for its function in protein-protein interactions (Deng2016Suppressor). The secondary structure of SIKE1 is characterized by alpha-helical content, typical of coiled-coil domains, as confirmed by circular dichroism (CD) spectra (forbes2010biochemical). This structural feature is important for the protein's ability to form interactions ranging from dimeric to heptameric complexes, which are essential for its role in the TLR3:interferon signaling pathway (forbes2010biochemical).

In terms of quaternary structure, SIKE1 can form multiple oligomeric states, including dimers and tetramers, as indicated by size exclusion chromatography and analytical ultracentrifugation studies (forbes2010biochemical). The protein's ability to self-associate and interact with other proteins, such as TBK1, is mediated by its coiled-coil domain (Deng2016Suppressor).

Post-translational modifications such as phosphorylation and ubiquitination have been investigated, although specific details on their impact on SIKE1's function are not fully elucidated (forbes2010biochemical). The protein's structural properties and interactions suggest its significant role in regulating immune responses and cardiac hypertrophy (Deng2016Suppressor).

## Function
SIKE1 (suppressor of IKBKE 1) is a gene that encodes a protein involved in regulating immune responses and maintaining cellular homeostasis. In healthy human cells, SIKE1 functions primarily as a negative regulator of the IKKε and TBK1 kinases, which are crucial for activating the type I interferon response pathway. This regulation is essential for controlling the production of interferons, which play a key role in the antiviral immune response (Marion2013Mechanism).

SIKE1 acts as a mixed-type inhibitor of TBK1, affecting the phosphorylation of IRF3, a transcription factor involved in the interferon response. By modulating TBK1 activity, SIKE1 helps maintain the balance of the immune response, preventing excessive inflammation and ensuring proper immune function (Marion2013Mechanism).

In addition to its role in immune regulation, SIKE1 is involved in DNA repair and genomic stability. It is a component of the STRIPAK complex, which is crucial for the repair of DNA double-strand breaks and maintaining genomic integrity. This function is particularly important in the cellular response to DNA damage, contributing to the prevention of cancer progression (An2022Combinatorial).

## Clinical Significance
SIKE1 (suppressor of IKBKE 1) plays a significant role in the regulation of pathological cardiac hypertrophy. Alterations in SIKE1 expression or function have been linked to various cardiac conditions. In cases of hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), SIKE1 expression is notably decreased, which correlates with increased activation of the TBK1/AKT signaling axis. This suggests that reduced SIKE1 levels may exacerbate cardiac remodeling and hypertrophy, contributing to the progression of these diseases (Deng2016Suppressor).

SIKE1 deficiency has been shown to promote cardiomyocyte enlargement and cardiac dysfunction, while its overexpression can mitigate these effects. This indicates that SIKE1 acts as a negative regulator of cardiac hypertrophy, and its downregulation can lead to increased heart weight, cardiac dilation, and fibrosis (Deng2016Suppressor).

The interaction between SIKE1 and TBK1 is crucial for its cardioprotective effects. Disruption of this interaction can negate SIKE1's influence on cardiac remodeling, highlighting the importance of maintaining normal SIKE1 function to prevent pathological cardiac conditions (Deng2016Suppressor). These findings suggest that SIKE1 could be a potential therapeutic target for treating cardiac hypertrophy and heart failure.

## Interactions
SIKE1 (suppressor of IKBKE 1) is involved in several protein interactions that play crucial roles in cellular signaling pathways. It directly interacts with TANK-binding kinase 1 (TBK1) and IκB kinase epsilon (IKKε), acting as a negative regulator by inhibiting the activation of interferon regulatory factor 3 (IRF3) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathways (forbes2010biochemical). SIKE1's interaction with TBK1 is particularly significant in the context of cardiac hypertrophy, where it regulates the TBK1-AKT signaling axis, crucial for its cardioprotective role (Deng2016Suppressor).

SIKE1 is also a key adaptor in the STRIPAK complex, where it interacts with STRN3 and SLMAP through coiled-coil domains. SIKE1 forms a homotetramer and a 2:1 heterotrimer with STRN3, and a 2:2 heterotetramer with SLMAP, facilitating the dynamic assembly of the STRIPAK complex, which is involved in Hippo signaling (Tang2019Architecture). These interactions are essential for the regulation of cell signaling pathways, including those involved in immune responses and cardiac function. SIKE1's role as a substrate for TBK1 and IKKε further highlights its regulatory capacity in these pathways (Shi2016STRIPAK).


## References


[1. (An2022Combinatorial) Liwei An, Zhifa Cao, Pingping Nie, Hui Zhang, Zhenzhu Tong, Fan Chen, Yang Tang, Yi Han, Wenjia Wang, Zhangting Zhao, Qingya Zhao, Yuqin Yang, Yuanzhi Xu, Gemin Fang, Lei Shi, Huixiong Xu, Haiqing Ma, Shi Jiao, and Zhaocai Zhou. Combinatorial targeting of hippo-stripak and parp elicits synthetic lethality in gastrointestinal cancers. Journal of Clinical Investigation, May 2022. URL: http://dx.doi.org/10.1172/jci155468, doi:10.1172/jci155468. This article has 14 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci155468)

[2. (Deng2016Suppressor) Ke-Qiong Deng, Aibing Wang, Yan-Xiao Ji, Xiao-Jing Zhang, Jing Fang, Yan Zhang, Peng Zhang, Xi Jiang, Lu Gao, Xue-Yong Zhu, Yichao Zhao, Lingchen Gao, Qinglin Yang, Xue-Hai Zhu, Xiang Wei, Jun Pu, and Hongliang Li. Suppressor of ikkɛ is an essential negative regulator of pathological cardiac hypertrophy. Nature Communications, June 2016. URL: http://dx.doi.org/10.1038/ncomms11432, doi:10.1038/ncomms11432. This article has 61 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms11432)

3. (forbes2010biochemical) BIOCHEMICAL CHARACTERIZATION OF SUPPRESSOR OF IKK-$\varepsilon$ AND NAK-ASSOCIATED PROTEIN 1. This article has 0 citations.

[4. (Shi2016STRIPAK) Z Shi, S Jiao, and Z Zhou. Stripak complexes in cell signaling and cancer. Oncogene, 35(35):4549–4557, February 2016. URL: http://dx.doi.org/10.1038/onc.2016.9, doi:10.1038/onc.2016.9. This article has 80 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2016.9)

[5. (Tang2019Architecture) Yang Tang, Min Chen, Li Zhou, Jian Ma, Yehua Li, Hui Zhang, Zhubing Shi, Qi Xu, Xiaoman Zhang, Ziyang Gao, Yun Zhao, Yunfeng Cheng, Shi Jiao, and Zhaocai Zhou. Architecture, substructures, and dynamic assembly of stripak complexes in hippo signaling. Cell Discovery, January 2019. URL: http://dx.doi.org/10.1038/s41421-018-0077-3, doi:10.1038/s41421-018-0077-3. This article has 51 citations.](https://doi.org/10.1038/s41421-018-0077-3)

[6. (Marion2013Mechanism) James D. Marion, Charlotte F. Roberts, R. Jason Call, Jonathan L. Forbes, Kristina T. Nelson, J. Ellis Bell, and Jessica K. Bell. Mechanism of endogenous regulation of the type i interferon response by suppressor of iκb kinase ϵ (sike), a novel substrate of tank-binding kinase 1 (tbk1). Journal of Biological Chemistry, 288(25):18612–18623, June 2013. URL: http://dx.doi.org/10.1074/jbc.m112.440859, doi:10.1074/jbc.m112.440859. This article has 18 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m112.440859)